Literature DB >> 3032235

Limited proteolysis of type I collagen at hyperreactive sites by class I and II Clostridium histolyticum collagenases: complementary digestion patterns.

M F French, K A Mookhtiar, H E Van Wart.   

Abstract

The initial proteolytic events in the hydrolysis of rat tendon type I collagen by the class I and II collagenases from Clostridium histolyticum have been investigated at 15 degrees C. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis has been used to detect the initial cleavage fragments of both the alpha 1(I) and alpha 2 chains, which migrate at different rates in the buffer system employed. Experiments with the class I collagenases indicate that the first cleavage occurs across all three chains of the triple helix close to the C-terminus to produce fragments whose alpha chains have molecular weights of approximately 88,000. The second cleavage occurs near the N-terminus to reduce the molecular weight of the alpha chains to 80,000. Initial proteolysis by the class II collagenases occurs across all three chains at a site in the interior of the collagen triple helix to give N- and C-terminal fragments with alpha-chain molecular weights of 35,000 and 62,000, respectively. The C-terminal fragment is subsequently cleaved to give fragments with alpha-chain molecular weights of 59,000. These results indicate that type I collagen is degraded at several hyperreactive sites by these enzymes. Thus, initial proteolysis by these bacterial collagenases occurs at specific sites, much like the mammalian collagenases. These results with the individual clostridial collagenases provide an explanation for earlier data which indicated that collagen is degraded sequentially from the ends by a crude clostridial collagenase preparation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032235     DOI: 10.1021/bi00377a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  33 in total

1.  A Trypanosoma cruzi-secreted 80 kDa proteinase with specificity for human collagen types I and IV.

Authors:  J M Santana; P Grellier; J Schrével; A R Teixeira
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  Identification of Clostridium histolyticum collagenase hyperreactive sites in type I, II, and III collagens: lack of correlation with local triple helical stability.

Authors:  M F French; A Bhown; H E Van Wart
Journal:  J Protein Chem       Date:  1992-02

3.  Kinetics of hydrolysis of type I, II, and III collagens by the class I and II Clostridium histolyticum collagenases.

Authors:  S K Mallya; K A Mookhtiar; H E Van Wart
Journal:  J Protein Chem       Date:  1992-02

4.  Enhancement of the structural stability of full-length clostridial collagenase by calcium ions.

Authors:  Naomi Ohbayashi; Noriko Yamagata; Masafumi Goto; Kimiko Watanabe; Youhei Yamagata; Kazutaka Murayama
Journal:  Appl Environ Microbiol       Date:  2012-06-08       Impact factor: 4.792

5.  Degradation of human collagen isoforms by Clostridium collagenase and the effects of degradation products on cell migration.

Authors:  Lei Shi; Ryan Ermis; Anastacia Garcia; Dale Telgenhoff; Duncan Aust
Journal:  Int Wound J       Date:  2010-04       Impact factor: 3.315

6.  Improved enzymatic isolation of fibroblasts for the creation of autologous skin substitutes.

Authors:  Hongjun Wang; Clemens A Van Blitterswijk; Marion Bertrand-De Haas; Arnold H Schuurman; Evert N Lamme
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Sep-Oct       Impact factor: 2.416

Review 7.  Diversity, Structures, and Collagen-Degrading Mechanisms of Bacterial Collagenolytic Proteases.

Authors:  Yu-Zhong Zhang; Li-Yuan Ran; Chun-Yang Li; Xiu-Lan Chen
Journal:  Appl Environ Microbiol       Date:  2015-07-06       Impact factor: 4.792

Review 8.  Experience in the use of collagenase clostridium histolyticum in the management of Peyronie's disease: current data and future prospects.

Authors:  María Alejandra Egui Rojo; Ignacio Moncada Iribarren; Joaquín Carballido Rodriguez; Juan Ignacio Martinez-Salamanca
Journal:  Ther Adv Urol       Date:  2014-10

Review 9.  Collagenase Clostridium histolyticum in the management of Peyronie's disease: a review of the evidence.

Authors:  Elizabeth J Traore; William Wang; Faysal A Yafi; Wayne J G Hellstrom
Journal:  Ther Adv Urol       Date:  2016-03-22

10.  Biodegradation of elastin-like polypeptide nanoparticles.

Authors:  Mihir Shah; Pang-Yu Hsueh; Guoyong Sun; Ho Yon Chang; Siti M Janib; J Andrew MacKay
Journal:  Protein Sci       Date:  2012-05-14       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.